Taiyo Yakuhin Of Japan Secures Inventories To Ensure Stable Supply
This article was originally published in PharmAsia News
Executive Summary
To prepare for upcoming changes in Japan's prescription drug forms, and anticipated increased competition in the generic drug business as a result of the change, Japanese generic drug giant, Nagoya-based Taiyo Yakuhin Co., announced it has secured a manufacturing inventory of seven and a half months and a retail inventory slightly over one and a half months of its 524 drug items. The move is also a follow up to Japan's Ministry of Health, Labor and Welfare's request of generic drug makers to secure a month's worth of both inventories. (Click here for more - Japanese language)